Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Renovis -- Ignore unavailable to you. Want to Upgrade?

To: Peter H. Proctor who wrote (7)	2/10/2004 8:36:05 PM
From: OverUnder	Read Replies (1) \| Respond to of 9

Peter: What is your motivation for posting here? If you have an actual IP claim, noting it in Silicon Investor doesn't do much to protect it, you should be pursuing something against Renovis. Obviously, if your claim is valid, you actually would want the company to succeed. Unless you are trying to commercialize this yourself, which is unlikely. Have you tried to settle with either Renovis or Centaur, or are you simply laying low until a clearer picture of value is created? If Peter's claim is valid, what do others think about how to fairly compensate him for his IP while still allowing Renovis to realize the value of their investments (and now mine)? (if anyone else is reading this thread) Hundreds of millions of dollars may go into approving a single drug and how do you allocate value creation to the "creator" of the drug and the investors and entrepreneurs who transform a possibility of a treatment into an actual approved drug?